Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-23

Clinical Trial Update: Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin [Phase 4]

View source ↗

Summary

Phase 4 trial comparing saxagliptin to glimepiride in Chinese patients with type 2 diabetes mellitus inadequately controlled on metformin, focusing on efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)
  • Saxagliptin (saxagliptin)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED